Genetic tests provide actionable results and guide
important and time sensitive health decisions
Admera Health’s Clinical Decision Support System
- Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
- Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
- Securely and easily refer a patient’s report to another physician
Everyone responds to
medications differently
Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics
Over 60 genes | Over 200 variants
Everyone responds to
medications differently
Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics
Over 50 genes | Over 200 variants
A courtesy consultation with experts in the field of pharmacogenomics is available Monday through Friday 8am to 8pm EST at 
844-4ADMERA (844.423.6372)
Everyone responds to medications differently
Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics
Over 50 genes | Over 200 variants
A courtesy consultation with experts in the field of pharmacogenomics is available Monday through Friday 8am to 8pm EST at 844-4ADMERA (844.423.6372)
What is Pharmacogenomics?
Pharmacogenomics (PGx) combines the study of genetics with the science of drug delivery
PGxOne™ Plus provides actionable reporting.
The PGxOne™ Plus report provides gene, genotype, and PGx related phenotype information providing an additional tool to manage patient care
Learn More >
What is Pharmacogenomics?
Pharmacogenomics (PGx) combines the study of genetics with the science of drug delivery
PGxOne™ Plus provides actionable reporting.
The PGxOne™ Plus report provides gene, genotype, and PGx related phenotype information providing an additional tool to manage patient care
Learn More >
Genetic testing that spans the continuum of patient care
Genetic testing that spans the continuum of patient care
LiquidGx
Non-invasive cancer testing for identifying
actionable mutations and treatment
monitoring from a blood sample.
Learn More >
OncoGxOne™ – Solid Tumor Profiling
Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.
Learn More >
LiquidGx
Non-invasive cancer testing for identifying actionable mutations and treatment monitoring from a blood sample.
Learn More >
Solid Tumor Profiling
Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.
Learn More >
Comprehensive genetic testing for inherited cardiovascular diseases
Comprehensive genetic testing for inherited cardiovascular diseases
AtheroGxOne™
Detects genetic variants responsible
for diseases that can cause early
atherosclerosis.
Learn More >
CardioGxOne™
Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.
Learn More >
AtheroGxOne™
Detects genetic variants responsible for diseases that can cause early atherosclerosis.
Learn More >
CardioGxOne™
Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.
Learn More >
1
Provide a buccal swab,
mouth wash, blood,
saliva sample, or FFPE*
*FFPE material is needed for
solid tumor profiling.
2
Ship the
specimen to
Admera Health
3
Admera Health
scientists sequence
and interpret DNA
4
Receive a
personalized
genetic report
